Merck stock price pushed toward $121 as healthcare ETFs

Merck stock price pushed toward $121 as healthcare ETFs see inflows. Investors watch for upcoming clinical trial results that could significantly influence valuation metrics. It may therefore be prudent to be a little cautious with the Buy-equivalent ABR for Merck. Stocks of most other large drugmakers like Merck gained too, as the Pfizer deal seems to have alleviated the two biggest concerns surrounding the drug and biotech industry this year – tariff and MFN pricing. MRK’s latest close puts Merck stock price at $120.40, supported by high dividend yield attractiveness. Institutional buying patterns remain evident in NYSE trade data.